Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 824850, 6 pages
http://dx.doi.org/10.1155/2015/824850
Research Article

Complex Networks Approach for Analyzing the Correlation of Traditional Chinese Medicine Syndrome Evolvement and Cardiovascular Events in Patients with Stable Coronary Heart Disease

1China Heart Institute of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100091, China
2Beijing University of Chinese Medicine, Beijing 100029, China
3School of Computer and Information Technology and Beijing Key Lab of Traffic Data Analysis and Mining, Beijing Jiaotong University, Beijing 100044, China

Received 30 August 2014; Revised 29 November 2014; Accepted 29 November 2014

Academic Editor: Myeong Soo Lee

Copyright © 2015 Zhuye Gao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. National Center for Cardiovascular Diseases (NCCD), Report on Cardiovascular Diseases in China (2011), Encyclopedia of China Publishing House, Beijing, China, 2012.
  2. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Heart disease and stroke statistics—2014 update: a report from the American Heart Association,” Circulation, vol. 129, no. 3, pp. e28–e292, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Montalescot, U. Sechtem, S. Achenbach et al., “ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology,” European Heart Journal, vol. 34, no. 38, pp. 2949–3003, 2013. View at Publisher · View at Google Scholar
  4. M. E. Pfisterer, M. J. Zellweger, and B. J. Gersh, “Management of stable coronary artery disease,” The Lancet, vol. 375, no. 9716, pp. 763–772, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. H. M. Xu, H. W. Cai, H. B. Dai et al., “Use of evidence-based pharmacotherapy for secondary prevention of coronary heart disease: a Chinese medicine hospital versus a general hospital,” Chinese Journal of Integrative Medicine, vol. 20, no. 5, pp. 375–380, 2014. View at Publisher · View at Google Scholar
  6. S. P. Sedlis, C. T. Jurkovitz, P. M. Hartigan et al., “Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post Hoc findings from the COURAGE trial),” American Journal of Cardiology, vol. 112, no. 11, pp. 1703–1708, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. F. Zhao, L. Y. He, B. Y. Liu et al., “Syndrome classification based on manifold ranking for viral hepatitis,” Chinese Journal of Integrative Medicine, vol. 20, no. 5, pp. 394–399, 2014. View at Publisher · View at Google Scholar
  8. J. Wang and G. Yu, “Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches,” Chinese Journal of Integrative Medicine, vol. 20, no. 3, pp. 163–169, 2014. View at Publisher · View at Google Scholar
  9. K.-J. Chen, “Blood stasis syndrome and its treatment with activating blood circulation to remove blood stasis therapy,” Chinese Journal of Integrative Medicine, vol. 18, no. 12, pp. 891–896, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. Cardiovascular Specialty Committee and China Association of Integrative Medicine, “Criterion of syndrome differentiation for CHD,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 11, p. 257, 1991. View at Google Scholar
  11. K. J. Chen, D. Z. Shi, H. Xu, H. J. Yin, and J. C. Zhang, “Ecchymosis mutagenic diagnostic quantitative criteria in Patients with stable coronary artery disease,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 31, pp. 313–314, 2011. View at Google Scholar
  12. N. Du, X. Zhou, R. Zhang, C. Jia, J. Yu, and B. Liu, “Multiscale backbone based network comparison algorithm for effective herbal interaction analysis,” in Proceedings of the 4th International Conference on Biomedical Engineering and Informatics (BMEI '11), pp. 1757–1762, Shanghai, China, October 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. Y.-Y. Liu, J.-J. Slotine, and A.-L. Barabási, “Controllability of complex networks,” Nature, vol. 473, no. 7346, pp. 167–173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Li, X. Zhou, R. Zhang et al., “Complex network approach for investigating the herb-symptom correspondence phenomenon and analyzing the TCM clinical herb-symptom association knowledge,” BMC Complementary and Alternative Medicine, 2014. View at Google Scholar
  15. X. Li, X. Zhou, Y. Peng et al., “Network based integrated analysis of phenotype-genotype data for prioritization of candidate symptom genes,” BioMed Research International, vol. 2014, Article ID 435853, 10 pages, 2014. View at Publisher · View at Google Scholar
  16. A.-L. Barabási, N. Gulbahce, and J. Loscalzo, “Network medicine: a network-based approach to human disease,” Nature Reviews Genetics, vol. 12, no. 1, pp. 56–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Cookson, L. Liang, G. Abecasis, M. Moffatt, and M. Lathrop, “Mapping complex disease traits with global gene expression,” Nature Reviews Genetics, vol. 10, no. 3, pp. 184–194, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. B. P. Kelley, R. Sharan, R. M. Karp et al., “Conserved pathways within bacteria and yeast as revealed by global protein network alignment,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 20, pp. 11394–11399, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. Z.-Y. Gao, J.-C. Zhang, H. Xu et al., “Analysis of relationships among syndrome, therapeutic treatment, and Chinese herbal medicine in patients with coronary artery disease based on complex networks,” Zhong Xi Yi Jie He Xue Bao, vol. 8, no. 3, pp. 238–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Jiao, S.-W. Li, Q.-H. Shang et al., “Multifactor dimensionality reduction analysis of the correlation of Chinese medicine syndrome evolvement and cardiovascular events in patients with stable coronary heart disease,” Chinese Journal of Integrative Medicine, vol. 20, no. 5, pp. 341–346, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Qiu, H. Xu, and D. Y. Zhao, “Therapeutic evaluation on complex interventions of integrative medicine and the potential role of data mining,” Chinese Journal of Integrative Medicine, vol. 16, no. 5, pp. 466–471, 2010. View at Publisher · View at Google Scholar
  22. L. Zhang, D. L. Yu, Y. G. Wang, and Q. M. Zhang, “Selecting an appropriate interestingness measure to evaluate the correlation between Chinese medicine syndrome elements and symptoms,” Chinese Journal of Integrative Medicine, vol. 18, no. 2, pp. 93–99, 2012. View at Publisher · View at Google Scholar
  23. H. Xu, D.-Z. Shi, and H.-J. Yin, “Blood-stasis and toxin causing catastrophe hypothesis and acute cardiovascular events: proposal of the hypothesis and its clinical significance,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 28, no. 10, pp. 934–938, 2008. View at Google Scholar · View at Scopus